Vertex Pharmaceuticals Inc (VRTX)

Health Care·equity

$510.08

+1.36% today

Extended hours $510.23

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

61/ 100

Score level

Above average

6 of 6 checks had data

Business numbers score (revenue, margins, returns) is near the top of its range — price trend score is on the high side.

VRTX scores higher than 86% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Vertex Pharmaceuticals Inc (VRTX) scores 61 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 1.46× 30-day average
52-week range: 402.58 – 560.25
Market cap: $121.09B
Earnings date: 2 Nov 2026

Volume: 1,480,845
Avg. volume (30d): 1,011,940

Open: 502.11
Previous close: 503.25
Day's range (regular session): 502.06 – 514.90

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.28
P/E (TTM): 29.09
EPS (TTM): 17.19

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for VRTX

5 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for VRTX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about VRTX right now

Vertex Pharmaceuticals Inc (VRTX) currently scores 61/100 on the Market Census six-factor composite, at the Above average score level. VRTX is +1.36% on the day and +1.30% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for VRTX leans good, with some weak spots. VRTX's strongest factor is price trend at 76/100 — a strong read on which way the price has been going. The weakest factor is market mood at 50/100 — middling backdrop. A weak market mood drags every name in the cohort; if VRTX is still scoring well on the composite despite this, the company-specific factors must be doing heavy lifting.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See VRTX in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score